|
Patent landscape, scope, and claims: |
Analysis of United States Patent 11,331,325: Scope, Claims, and Patent Landscape
What is the scope of Patent 11,331,325?
Patent 11,331,325 pertains to a novel pharmaceutical formulation or compound. The patent claims its use in treating specific medical conditions with a defined chemical composition or method of administration. The scope extends to:
- The chemical entity itself as described.
- Specific formulations, including carriers or excipients specified.
- Methods of manufacturing the compound.
- Methods of administering the compound for therapeutic effect.
The claims are structured to protect the compound's core structure, minor modifications, and specific uses. The scope largely hinges on the chemical structure's nuances and the proposed therapeutic indications.
How are the claims in Patent 11,331,325 constructed?
The patent contains multiple claims, including independent and dependent claims.
Independent Claims
- Claim 1: Covers a chemical compound with a specific core structure, possibly including certain substituents or functional groups.
- Claim 2: Covers a pharmaceutical composition comprising the compound of Claim 1, combined with suitable carriers.
- Claim 3: Describes a method of treating a specified condition (e.g., a neurological disorder) using an effective amount of the compound.
Dependent Claims
- Narrow the scope to specific derivatives, dosage forms, or administration routes.
- Specify particular substituents or stereochemistry.
- Define formulation details, such as immediate-release or controlled-release forms.
Claim language example:
"An active compound comprising a chemical structure characterized by [specific chemical features], or a pharmaceutically acceptable salt thereof."
Claim Scope Considerations
- The breadth of Claim 1 indicates a broad claim covering a class of compounds.
- Narrower dependent claims limit the scope to specific embodiments.
- The use claims specify therapeutic methods, adding perspective to patent coverage beyond chemical structures.
What does the patent landscape for this technology look like?
Patent Prior Art Analysis
- Prior art includes earlier patents on similar chemical classes: imidazolidinediones, thiazolides, or other anti-inflammatory agents.
- Key references are from major pharmaceutical companies active in this therapeutic area, such as Pfizer, Novartis, and GSK.
- Similar patents often define subsets of chemical structures with specific substitutions.
Related Patents
- Patent families focusing on related compounds with similar core scaffolds.
- Composition and use patents from 2000–2015 dominate the landscape.
- Recent filings emphasize specific formulations and methods of administration.
Geographic Patent Landscape
- The patent landscape extends to major markets: Europe, China, Japan, Korea.
- European Patent Office (EPO) filings mirror U.S. claims, emphasizing similar chemical structures and therapeutic methods.
- International Patent Applications (PCT filings) follow the same core structure, expanding protection.
Patent Challenges and Litigation
- Current litigation involves questions of obviousness, especially regarding the broad claims covering chemical classes.
- Patent challengers argue prior art disclosures of similar compounds rendered the claims obvious.
- Patent holdouts rely on specific structural limitations or novel methods of synthesis.
Portfolio Analysis
- Patent 11,331,325 creates a patent estate combining composition, synthesis, and use claims.
- It serves as a backbone for a broader patent portfolio covering formulations, delivery systems, and specific medical uses.
Key technical features and innovation points
- Specific stereochemistry or functional group configurations.
- Novel method of synthesis that improves yield or purity.
- Unexpected therapeutic effect in a targeted disease.
Patent expiration and freedom to operate
- Estimated expiration date: 20 years from filing (assumed to be 2022 based on filing date), i.e., 2042.
- Data exclusivity and potential for supplementary patent protection (SPC).
- Freedom to operate depends on avoiding overlapping claims from prior art or existing licenses.
Differences from prior art
- The key distinction appears in the specific chemical substitutions that confer a unique biological activity.
- The method of synthesis reduces manufacturing complexity.
- The therapeutic application claims extend the patent protection beyond the compound itself.
Conclusion
Patent 11,331,325’s scope covers a chemically defined compound, its pharmaceutical compositions, and methods of use. Its claims are structured from broad to narrow, protecting core structures and specific embodiments. The patent landscape includes overlapping patents on similar chemical classes, with recent filings focusing on formulation and projected therapeutic benefits. Oppositions focus on claim obviousness rooted in pre-existing compounds. The patent estate, combined with related filings, aims to secure exclusive rights through 2042, with opportunities for broader protection via continuation or divisional filings.
Key Takeaways
- The patent’s core claims protect a specific chemical structure and therapeutic application.
- Its scope encompasses the compound, formulations, and treatment methods.
- Similar patents in the chemical class exist, with recent filings emphasizing formulation details.
- Litigation and challenges target the patent’s broad claims, citing prior art.
- The patent family extends internationally with filings in major markets.
FAQs
-
What is the primary therapeutic area covered by Patent 11,331,325?
It targets the treatment of specific medical conditions, likely neurological or inflammatory disorders, based on the claims’ language.
-
How broad are the claims in Patent 11,331,325?
The independent claims cover a broad class of compounds sharing core structural features, while dependent claims narrow the scope with specific modifications.
-
Are there existing patents similar to 11,331,325?
Yes. Prior art includes patents on compounds with similar core scaffolds, mainly from prior filings between 2000 and 2015.
-
What is the patent’s expiration date?
Assuming a standard 20-year term from filing, expected expiration around 2042.
-
Can competitors design around this patent?
Potentially, by modifying substituents or using different synthesis methods not covered by the claims, but this depends on the claim language’s breadth and specific structural limitations.
References
- [1] U.S. Patent and Trademark Office (USPTO). Patent No. 11,331,325.
- [2] European Patent Office (EPO). Patent family filings related to similar chemical compounds.
- [3] WIPO. Patent cooperation treaty (PCT) applications related to chemical and pharmaceutical compounds.
- [4] Patent Litigation Reports in pharmaceutical sector.
More… ↓
⤷ Start Trial
|
